By Linda Chiem ( October 3, 2014, 8:43 PM EDT) -- California-based biopharmaceutical company Dermira Inc. debuted on the public markets Friday with a $125 million initial public offering as it seeks to expand research and development of its potential treatments for psoriasis and other skin conditions, blowing past its initial goal of raising $75 million....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.